Zhou X - Search Results

1

Impact of the Updated 2018 American Society of Clinical Oncology/College of American Pathologists Guideline for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.

Li A, Bai Q, Kong H, Zhou S, Lv H, Zhong S, Li M, Bi R, Zhou X, Yang W. Li A, et al. Among authors: zhou x, zhou s. Arch Pathol Lab Med. 2020 Sep 1;144(9):1097-1107. doi: 10.5858/arpa.2019-0369-OA. Arch Pathol Lab Med. 2020. PMID: 32142367 Free article.

2

ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression.

Yang W, Klos KS, Zhou X, Yao J, Yang Y, Smith TL, Shi D, Yu D. Yang W, et al. Among authors: zhou x. Cancer. 2003 Sep 15;98(6):1123-30. doi: 10.1002/cncr.11625. Cancer. 2003. PMID: 12973835 Free article.

3

Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone.

Klos KS, Zhou X, Lee S, Zhang L, Yang W, Nagata Y, Yu D. Klos KS, et al. Among authors: zhou x. Cancer. 2003 Oct 1;98(7):1377-85. doi: 10.1002/cncr.11656. Cancer. 2003. PMID: 14508823 Free article.

4

Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line.

Sellappan S, Grijalva R, Zhou X, Yang W, Eli MB, Mills GB, Yu D. Sellappan S, et al. Among authors: zhou x. Cancer Res. 2004 May 15;64(10):3479-85. doi: 10.1158/0008-5472.CAN-3299-2. Cancer Res. 2004. PMID: 15150101

5

[Study of mutations in 5'-noncoding region of BCL-6 gene in B-cell non-Hodgkin's lymphomas].

Min DL, Zhou XY, Yang WT, Sun MH, Lu HF, Zhang TM, Zheng AH, Cao PZ, Shi DR. Min DL, et al. Zhonghua Bing Li Xue Za Zhi. 2004 Jun;33(3):238-41. Zhonghua Bing Li Xue Za Zhi. 2004. PMID: 15256116 Chinese.

6

Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.

Zhou X, Tan M, Stone Hawthorne V, Klos KS, Lan KH, Yang Y, Yang W, Smith TL, Shi D, Yu D. Zhou X, et al. Clin Cancer Res. 2004 Oct 15;10(20):6779-88. doi: 10.1158/1078-0432.CCR-04-0112. Clin Cancer Res. 2004. PMID: 15501954

7

Point mutation of 5' noncoding region of BCL-6 gene in primary gastric lymphomas.

Min DL, Zhou XY, Yang WT, Lu HF, Zhang TM, Zhen AH, Cao PZ, Shi DR. Min DL, et al. World J Gastroenterol. 2005 Jan 7;11(1):51-5. doi: 10.3748/wjg.v11.i1.51. World J Gastroenterol. 2005. PMID: 15609396 Free PMC article.

8

[Analysis of bcl-6 protein expression and gene rearrangement in diffuse large B-cell lymphoma].

Min DL, Xia HL, Zhou XY, Sun MH, Yang WT, Zhang TM, Zheng AH, Shi DR. Min DL, et al. Zhonghua Bing Li Xue Za Zhi. 2005 Jun;34(6):327-31. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 16185497 Chinese.

9

[Preliminary analysis of mutations in exon 5 of IkappaBalpha gene in Hodgkin lymphoma].

Liu XJ, Yang WT, Zhou XY, Yan Q, Shi DR. Liu XJ, et al. Zhonghua Bing Li Xue Za Zhi. 2005 Jun;34(6):341-4. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 16185501 Chinese.

10

ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.

Klos KS, Wyszomierski SL, Sun M, Tan M, Zhou X, Li P, Yang W, Yin G, Hittelman WN, Yu D. Klos KS, et al. Among authors: zhou x. Cancer Res. 2006 Feb 15;66(4):2028-37. doi: 10.1158/0008-5472.CAN-04-4559. Cancer Res. 2006. PMID: 16489002 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,505 results

Search Page

Filters